Results 201 to 210 of about 320,412 (378)
Pneumonectomy with Immediate Thoracoplasty in the Treatment of Pulmonary Tuberculosis [PDF]
G. Cruickshank, El Papamichael
openalex +1 more source
Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications
Abstract Nutraceuticals have emerged as potential compounds to attenuate the COVID‐19 complications. Precisely, these food additives strengthen the overall COVID treatment and enhance the immunity of a person. Such compounds have been used at a large scale, in almost every household due to their better affordability and easy access.
Keshav Raj Paudel+19 more
wiley +1 more source
SIMULTANEOUS BILATERAL RESECTION FOR PULMONARY TUBERCULOSIS IN MENTAL PATIENTS
F. John Lewis+6 more
openalex +1 more source
THE POINT OF ELECTION AND MODES OF INVASION IN PULMONARY TUBERCULOSIS [PDF]
J. O. Cobb
openalex +1 more source
Abstract Mycobacterium marinum is a prevalent nontuberculous mycobacterium (NTM)‐infecting teleosts. Conversely, little is known about mycobacteriosis in elasmobranchs, and M. marinum infection has never been reported from the subclass. This study investigated the histopathological characteristics and localization of this mycobacterium through ...
Mari Inohana+4 more
wiley +1 more source
Tuberculosis in Malta : a case for sputum induction [PDF]
Sputum induction is a procedure used to help patients expectorate samples of sputum for laboratory analysis. It is a simple, safe and standardised procedure which may avoid the use of more invasive and potentially harmful interventions such as fibreoptic
Farrugia, Brian
core
How is the Early Diagnosis of Pulmonary Tuberculosis to be Made? [PDF]
E. D. D. Davis
openalex +1 more source
Pulmonary cytology in tuberculosis.
A review was made of 138 sputa, 4 bronchial washings and 4 bronchial aspirates from 64 patients with pulmonary tuberculosis. The cytologic findings that may indicate granulomatous involvement were epithelioid cells, giant cells, lymphocytes and a necrotic background.
Tani, E. M.+4 more
openaire +2 more sources
Abstract Guselkumab is a monoclonal antibody that binds to the p19 subunit of interleukin‐23 and inhibits its downstream signaling. The safety profile of guselkumab and its superior efficacy over placebo and adalimumab for the treatment of patients with moderate‐to‐severe psoriasis were reported in phase 3 studies conducted within and outside Japan. To
Yayoi Tada+6 more
wiley +1 more source
Abstract Hepatitis B, caused by the hepatitis B virus (HBV), is a global public health issue that affects 290 million people worldwide. Most people with hepatitis B are in low‐ and middle‐income countries (LMIC), where health systems and resources are often constrained.
Caroline Lee+2 more
wiley +1 more source